Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal RRM1 Primary Antibody for WB - ABIN2782438
Inglis: Requirement of arginine for the replication of herpes virus. in The Journal of general virology 1970
Show all 4 Pubmed References
Human Polyclonal RRM1 Primary Antibody for WB - ABIN1881767
Ucisik-Akkaya, Davis, Do, Morrison, Stemmer, Amadio, Dorak: Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. in Molecular human reproduction 2010
Show all 2 Pubmed References
Human Monoclonal RRM1 Primary Antibody for FACS, IHC (p) - ABIN1687336
Ulker, Duman, Sahin, Gumurdulu: ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine. in Contemporary oncology (Poznań, Poland) 2015
The genetic polymorphisms RRM1 -756T>C and -269C>A may not be a factor for susceptibility to cervical neoplasia
Based on the results of clinical trials, we conclude that Ribonucleotide reductase (RR) enzymes (RR1 and RR2 (show RRM2 Antibodies))inhibitors are viable treatment options, either as a monotherapy or as a combination in cancer chemotherapy. With the recent advances made in cancer biology, further development of RR inhibitors with improved efficacy and reduced toxicity is possible for treatment of variety of cancers.
RRM1 single nucleotide polymorphism is associated with Non-Small-Cell Lung Cancer.
RRM1/RRM2B (show RRM2B Antibodies) enzyme is capable of retaining activity in hypoxia and therefore is favored over RRM1/RRM2 (show RRM2 Antibodies) in order to preserve ongoing replication and avoid the accumulation of DNA damage in hypoxic cells.
findings suggest that the up-regulated RRM1 and hTrx1 (show MLL Antibodies) in colorectal cancer directly interact with each other and promote RR activity, resulting in enhanced DNA synthesis and cancer malignancy.
RRM1 and ERCC1 (show ERCC1 Antibodies) expression levels did not show any relationship with overall survival.
RRM1 and ERCC wild type alleles are risk-reducing factor for Coronary artery disease (CAD (show CAD Antibodies)). Also, carrying RRM1 A allele might have a protective effect for smokers.
Presence of rare AA (-37C>A) and CC (-524C>T) genotypes of the RRM1 may be favorable predictive factors for chemotherapy with platinum compounds and gemcitabine in non-small cell lung cancer patients.
study finds that ERCC1 (show ERCC1 Antibodies) and RRM1 are not independent prognostic factors of recurrence in stage I non-small cell lung cancer patients
mRNA expression of RRM1 was closely associated with cell proliferation and varied in seven non-Hodgkin lymphoma cell lines.
This study provides an improved understanding of the molecular basis (structure and dynamics) that governs the binding of the p54(nrb)/NonO (show NONO Antibodies) RRM1 to one of its target RNAs.
This work reveals that binding of RRM1 to RRM2 (show RRM2 Antibodies) is essential for mammalian cells and provides the first loss-of-function model of the ribonucleotide reductase complex for genetic studies.
analysis of transgenic overexpression of ribonucleotide reductase Rrm1 and Rrm2 (show RRM2 Antibodies) improves cardiac performance
silencing RRM1 expression using siRNA could potentially be an effective strategy to overcome gemcitabine resistance.
Tip60 (show KAT5 Antibodies)-dependent recruitment of RNR (show REN1 Antibodies) plays an essential role in dNTP supply for DNA repair
The hexamer form of murine ribonucleotide reductase (mRR) large catalytic subunit mR1 (show MR1 Antibodies)(6) predominates over the dimer form mR1 (show MR1 Antibodies)(2) in the cytoplasm of normal cells, where the great majority of mRR activity is located.
overexpression of RRM1 in human and mouse lung cancer cell lines induced PTEN expression, reduced phosphorylation of focal adhesion kinase (FAK), suppressed migration, invasion, and metastasis formation, and increased survival in an animal model.
This gene encodes one of two non-identical subunits that constitute ribonucleoside-diphosphate reductase, an enzyme essential for the production of deoxyribonucleotides prior to DNA synthesis in S phase of dividing cells. It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region.
ribonucleoside diphosphate reductase large subunit
, ribonucleoside diphosphate reductase M1 subunit
, ribonucleoside-diphosphate reductase large subunit
, ribonucleoside-diphosphate reductase M1 chain
, ribonucleotide reductase M1 polypeptide
, ribonucleotide reductase M1
, ribonucleoside-diphosphate reductase large subunit-like
, ribonucleoside-diphosphate reductase subunit M1
, ribonucleotide reductase, R1 subunit
, ribonucleotide reductase large subunit
, ribonucleotide reductase protein r1 class I